Biotek-snakken — December 2021
-
-
-
-
Lexus….man kan vel sige at HVIS deres planer lykkedes, kan det være en god langsigtet aktie, med meget mindre risiko og udgifter til godkendelses proceduren. Prøv at se nogle af deres præsentationer her fra hjemmesiden: https://xbrane.com/en/investors-media/presentations-2/
-
Immunic's IMU-935 Demonstrates
Favorable Safety Profile In Phase I Trial https://www.proinvestor.com/investornyt/749109/immunics-imu-935-demonstrates-favorable-safety-profile-in-phase-i-trial -
Shares of Galera Therapeutics Inc. (GRTX) skyrocketed 95% on Tuesday, thanks to corrected results from its ROMAN trial...https://www.proinvestor.com/investornyt/749535/a-second-look-at-galera-therapeutics
-
Nektar Announces Positive Phase 1b Data For NKTR-358 In Patients With Atopic Dermatitis https://www.proinvestor.com/investornyt/749759/nektar-announces-positive-phase-1b-data-for-nktr-358-in-patients-with-atopic-dermatitis
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind